Food Pathogen Safety Testing Equipment & Supplies Market

The food pathogen safety testing equipment & supplies market is estimated to be USD 9.10 billion in 2026 and is projected to reach USD 13.25 billion by 2031, at a CAGR of 7.8%. The market is experiencing tremendous growth in the global market due to rising consumer awareness with regard to food safety, quality, and transparency. The increasing prevalence of foodborne illnesses has made food producers, laboratories, and food regulatory authorities adopt the latest and improved methods of detection and guarantee safer food throughout the supply chain. PCR analyzers, rapid detection kits, immunoassays, and automated screening systems are all enhancing speed, accuracy, and reliability so that the stakeholders can soon discover some of the harmful bacteria, viruses, and toxins. Additional adoption of innovation in sample preparation, data analytics, and high-throughput testing, smart regulations, and industry standards is also boosting adoption in the food, beverage, and agrifood industries. Due to the increased demand for minimally processed, ready-to-eat, and clean-label foods, the requirement for reliable and scalable testing solutions is not only to meet regulatory requirements, but also to generate consumer confidence and protect human health. The cooperation between the equipment developers, research centers, and food organizations is constantly improving the effectiveness and availability of those technologies, opening the way to better and safer, more transparent, and resilient food ecosystems in the world.

The market is also motivated by an increased consumer attention given to food safety, and the increased awareness of foodborne diseases, as well as the growing demand for high-quality foods, low-processed foods, and ready-made foods. Major players in the food pathogen safety testing equipment & supplies market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Neogen Corporation (US), bioMérieux (France), Agilent Technologies, Inc. (US), QIAGEN (Germany), Shimadzu Corporation (Japan), Bruker (US), PerkinElmer Inc. (US), Hygiena, LLC (US), Solabia Group (France), Roka Bio Science (US), Promega Corporation (US), Romer Labs Division Holding (Austria) and others. The strategic efforts being implemented by these firms include partnering, acquiring, building additional capacities, and developing new products to strengthen their presence in the market, as well as supporting the soaring demand for improved food pathogen testing instruments.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific Inc. is a leading global provider of science solutions, catering to a wide range of customers, including those in the pharmaceutical and biotech industries, hospitals, clinical diagnostic labs, universities, research institutions, and government agencies, as well as environmental, industrial quality, and process control settings. The company offers a diverse product portfolio comprising technologies, software, and services, and has a vast global network to meet the ever-changing demands of its customers. The company operates through four business segments:

• Life Sciences Solutions: The life sciences solutions segment of the company provides a broad range of reagents, instruments, and consumables utilized in medical and biological research, drug discovery and production, and the diagnosis of infection and disease.
• Analytical Instruments: The company provides various equipment, supplies, software, and services in its analytical instruments sector, which are utilized for multiple laboratories, production, and field applications. These products and services are used by customers in biotechnology, pharmaceutical, academic, government, environmental, and other research and industrial markets and in clinical laboratories. This sector comprises three main businesses: chromatography and mass spectrometry, chemical analysis, and materials and structural analysis.
• Specialty Diagnostics: The specialty diagnostics segment of the company offers a range of diagnostic test kits, reagents, culture media, instruments, and related items to customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
•  Laboratory Products and Biopharma Services: This includes laboratory products, laboratory chemicals, research and safety market channel, pharma services, and clinical research.

The company has a business segment that is specifically dedicated to analytical instruments and specialty diagnostics, which includes products and instruments for food pathogen safety testing. These products are sold under different brands, including Applied Biosystems and Thermos Scientific. The company operates in over 150 countries across North America, Europe, Asia, and South America. Some of its major subsidiaries include Thermo Fisher Scientific Peru S.A., Laboratory Management Systems, Inc. (US), Open Biosystems, Inc. (US), Thermo Fisher Scientific Korea Ltd. (South Korea), Fisher Clinical Services LLC (Russia), Fisher Clinical Services Japan K.K. (Japan), and Thermo Fisher Scientific C.V. (Netherlands).

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a multinational manufacturer and global distributor of clinical diagnostics and life science research products. The company designs, develops, manufactures, and supplies products and systems for life science research, healthcare, analytical chemistry, and other markets. The company operates through three major segments:

• Life Sciences: The life sciences segment develops, manufactures, sells, and services biological research reagents, apparatus, and instruments. These products are sold to laboratories at universities and medical schools, pharmaceutical and biotechnology firms, food testing laboratories, and government and industrial research facilities.
• Clinical Diagnostics: The clinical diagnostics segment creates, manufactures, sells, and supports automated test systems, informatics systems, test kits, and specialized quality controls for the healthcare industry. These products are sold to reference laboratories, hospital laboratories, state newborn screening facilities, doctors' offices, and transfusion laboratories.
• Other Operations: this category covers the analytical instruments segment and a small miscellaneous operation involving corporate activities.

The instruments, kits, and microbial culture media for food pathogen safety testing are sold under the life science segment of the company's business. In the life sciences market, various reagents, apparatus, and laboratory instruments are developed, manufactured, and marketed to a global customer base. Bio-Rad serves research and healthcare industry customers through its global network of operations in more than 138 countries. The company majorly operates across Europe, the US, Canada, Latin America, Africa, and Asia.

Merck KGaA

Merck KGaA is a leading science and technology company headquartered in Germany. Since 1668, the company has been producing technology and scientific brands. The company operates in three business sectors, as listed below:

• Life Sciences: The life sciences business segment of the company is engaged in the manufacture and supply of tools, chemicals, equipment, and services to research laboratories, pharmaceutical & biotech manufacturing, and industrial & testing laboratories.
• Healthcare: This segment designs and develops medicines and intelligent devices for patient support and treatment, including therapeutic areas such as oncology, neurology & immunology, fertility, endocrinology, and general medicine.
• Electronics: This segment provides advanced materials, equipment, and services such as
  semiconductors, display solutions, surface solutions, and automotive.

The company offers instruments, test kits, and reagents for food pathogen safety testing under its life sciences segment through its brand Sigma-Aldrich. The company covers more than 100 countries across the globe, with regions such as Africa, Asia, Europe, Latin America, North America, and Oceania. It has over 59 manufacturing sites for its life science business operations around the world, including more than 100 distribution sites worldwide for its life sciences business segment.

Market Ranking

Thermo Fisher Scientific Inc. stands as the foremost leader in the food pathogen safety testing market, offering a comprehensive portfolio that includes PCR-based detection systems and mass spectrometry platforms, supported by a strong global presence in over 150 countries. Following closely, Bio-Rad Laboratories, Inc. excels with its Life Sciences and Clinical Diagnostics segments, providing essential reagents and molecular diagnostics across more than 138 countries. Merck KGaA leverages its diverse segments to deliver microbiological testing solutions for food safety in over 100 countries. At the same time, Neogen Corporation focuses distinctly on food and animal safety, offering diagnostic test kits and pathogen detection solutions internationally. bioMérieux, also a top-five leader, is recognized for its automated pathogen detection systems, maintaining significant influence in the market with operations in more than 160 countries and a robust subsidiary network.

The global market for food pathogen safety testing equipment & supplies is experiencing significant growth, driven by increased consumer demand for safer, higher-quality, and minimally processed foods, alongside a heightened awareness of foodborne illnesses and a tightening of regulatory standards. The implementation of advanced detection technologies, including PCR-based analyzers, rapid detection kits, immunoassays, enrichment media, and automated sample preparation systems, is enabling more rapid, accurate, and reliable pathogen testing throughout the food supply chain. Technological advancements are further bolstered by collaborations with research institutions, laboratories, and food manufacturers, while regulatory support and adherence to industry standards provide a robust framework for growth. The market is expected to experience steady expansion, embracing modern food safety testing solutions as investments increase, attention to workflow automation intensifies, and the focus on improving public health and consumer confidence expands.

Related Reports:

Food Pathogen Safety Testing Equipment & Supplies Market by Type (Systems [Hybridization-Based, Chromatography-Based, Spectrometry-Based, Immunoassay-Based], Consumables & Supplies [Test Kits, Microbial Culture Media, Reagents & Other Consumables]), Food Tested (Meat & Poultry, Fish & Seafood, Processed Food, Fruits & Vegetables, Dairy Products, Cereals & Grains, Other Food Products), by Site (In-House Laboratories [Factory Labs], Outsourcing Facilities [Service Labs], Government Labs), Technology (Qualitative), and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com